Atossa Therapeutics, Inc.ATOSNASDAQ
Loading
Year-over-year earnings per share growth rate
Percentile
P38
Within normal range
vs 5Y Ago
-0.2x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | -3.27% |
| Q2 2025 | -25.38% |
| Q1 2025 | -3.79% |
| Q4 2024 | 12.87% |
| Q3 2024 | -19.54% |
| Q2 2024 | -2.56% |
| Q1 2024 | 24.23% |
| Q4 2023 | -25.05% |
| Q3 2023 | 36.21% |
| Q2 2023 | -56.45% |
| Q1 2023 | 16.22% |
| Q4 2022 | 6.48% |
| Q3 2022 | -20.11% |
| Q2 2022 | -39.42% |
| Q1 2022 | 1.05% |
| Q4 2021 | 7.06% |
| Q3 2021 | 29.02% |
| Q2 2021 | -51.57% |
| Q1 2021 | 52.72% |
| Q4 2020 | 76.24% |
| Q3 2020 | 20.93% |
| Q2 2020 | -34.37% |
| Q1 2020 | -10.34% |
| Q4 2019 | 19.44% |
| Q3 2019 | 55.00% |
| Q2 2019 | -29.03% |
| Q1 2019 | -93.75% |
| Q4 2018 | 50.00% |
| Q3 2018 | 87.40% |
| Q2 2018 | 40.09% |
| Q1 2018 | -1030.67% |
| Q4 2017 | 64.45% |
| Q3 2017 | 72.67% |
| Q2 2017 | -42.96% |
| Q1 2017 | 32.50% |
| Q4 2016 | -1087.65% |
| Q3 2016 | 110.14% |
| Q2 2016 | 31.83% |
| Q1 2016 | 58.65% |
| Q4 2015 | -0.96% |